This review aims to summarize the diverse proposed pathophysiological mechanisms
contributing to postpartum depression, highlighting both clinical and basic science research …

Major depressive disorder (MDD) is a heritable neuropsychiatric disease associated with
severe changes at cellular and molecular levels. Its diagnosis mainly relies on the …

Background: It is generally believed that selective serotonin reuptake inhibitor (SSRI) drugs
increase the risk of abnormal bleeding and decrease the risk of ischemic heart disease …

Peripartum depression affects up to one in seven women and is associated with significant
maternal and neonatal morbidity if untreated. A history of depression is the strongest risk …

Mood disorders disproportionately affect women across the lifespan. Mood disorders in
pregnancy and the postpartum period are common and have profound implications for …

Introduction: Anxiety disorders manifest in women more than in men by almost twofold. This
narrative review aims to summarize the sex-related biological factors, which underpin …

In comparison with the vast epidemiological literature on postpartum depression (PPD),
relatively few studies have examined the biological aspects of the disorder. However …

Emerging research points to a valuable role of the monoamine neurotransmitter, serotonin,
in the display of maternal behaviors and reproduction-associated plasticity in the maternal …

Central fatigue leads to reduced ability to perform mental tasks, disrupted social life, and
impaired brain functions from childhood to old age. Regarding the neurochemical …

This article describes the critical role of neurosteroids in postpartum depression (PPD) and
outlines the landmark pharmacological journey of brexanolone as a first-in-class …